What neoadjuvant therapy will you give to a premenopausal woman with cT2N0 metaplastic triple negative breast cancer?

A stage 2 metaplastic TNBC is considered a high risk, relatively chemorefractory rare subtype case with limited data regarding optimal treatment. Multiple studies have shown metaplastic tumors demonstrate higher levels of PDL1. (Grabenstetter et al., PMID 34115674) Sylvia Adams has published some re...

I completely agree with Dr. @Dr. First Last. Given the high risk nature of her cancer and younger age, I would follow the KEYNOTE-522 regimen. We understand that metaplastic tumors are less responsive to chemotherapy but our current approach is to treat these tumors like non-metaplastic triple negat...

I agree with the above comments (excluding Dr. @Dr. First Last's suggestion to give AC-T with pembrolizumab - omitting carboplatin would be a mistake as this is likely to reduce achievement of pCR and compromise long-term outcomes, based on results from a number of trials, including the one presente...